Since its inauguration in 2010, the Discovery to Cure International Clinical and Translational Research Fellowship has welcomed outstanding physicians from throughout the world to the Yale School of Medicine. The program offers physicians a three-month surgical observership or a research opportunity for up to 12 months in gynecologic oncology. To date, over 20 physicians from Europe, China, Japan and South America have successfully completed the Program in gynecologic oncology. Recently the program has been expanded and now offers a fellowship in Maternal Fetal Medicine.
The Discovery to Cure Fellowship Program was established with the purpose of motivating and advancing the ability of physicians from around the world to conduct clinical trials and translational research. Following completion of the program participants return to their home countries prepared to set up a research team and the supportive infrastructure for conducting translational research studies.
Successful applicants to the new Maternal Fetal Fellowship benefit from a full year's participation in the Yale Pregnancy Outcome Prediction Study (YPOPS).
During their time at Yale, DTC Fellowship physicians receive education and training in the design and conduct of clinical trials. They master review, analysis and reporting of clinical trial safety and efficacy; basic concepts of cellular and molecular research; and design and performance of translational and research studies. Both professional and practical experience are gained in a number of relevant areas -- from budget calculation and negotiation; interactions with the Grants and Contracts office; and writing an application and submitting a clinical trial to the Scientific Review Committee and Institutional Review Board (IRB) -- to collection and analysis of samples from patients enrolled in clinical studies; and clinical studies conduction with the support of a research team, including a coordination nurse and data manager.
Although DTC Fellowship participants do not take part in direct patient care or management, the Surgical Observership in gynecologic oncology gives participants in-depth exposure to state-of-the-art techniques in both open, laparoscopic and robotic surgical procedures while the Research Fellowship offers up to 12 months hands-on in a Discovery to Cure laboratory. DTC Fellows in Maternal Fetal Medicine may observe clinical care and perform research-only ultrasound examinations, Doppler and 3D exams.
To qualify for this Program, applicants must have completed medical school in their country, with a certification equivalent to M.D. They must have completed a substantial part of training in the specialty related to the DTC Fellowship for which they are applying, and they must be able to communicate and write clearly in English.
Directors of the Discovery to Cure International Clinical and Translational Research Fellowship Program in Gynecologic Oncology are Dan-Arin Silasi, MD and Gil Mor, MD, PhD, MSc.
Directors of the Discovery to Cure International Clinical and Translational Research Fellowship Program in Maternal Fetal Medicine are Radek Bukowski, MD, PhD and Michael Bracken, PhD, MPH.
Janice P. Marcus